GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 15 filers reported holding GW PHARMACEUTICALS PLC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $21,655,000 | -24.0% | 311,853 | 0.0% | 13.09% | +79.2% |
| Q3 2015 | $28,494,000 | -25.6% | 311,853 | 0.0% | 7.30% | -32.4% |
| Q2 2015 | $38,308,000 | +34.8% | 311,853 | 0.0% | 10.81% | +65.2% |
| Q1 2015 | $28,419,000 | +34.6% | 311,853 | 0.0% | 6.54% | +12.7% |
| Q4 2014 | $21,106,000 | -16.3% | 311,853 | 0.0% | 5.81% | -48.8% |
| Q3 2014 | $25,213,000 | -24.6% | 311,853 | 0.0% | 11.33% | -36.6% |
| Q2 2014 | $33,459,000 | -12.5% | 311,853 | -51.6% | 17.88% | -10.1% |
| Q1 2014 | $38,257,000 | +31.7% | 644,376 | -7.9% | 19.89% | +27.2% |
| Q4 2013 | $29,052,000 | +100.0% | 699,376 | -16.5% | 15.63% | +94.9% |
| Q3 2013 | $14,527,000 | +96.8% | 837,800 | 0.0% | 8.02% | +46.4% |
| Q2 2013 | $7,381,000 | – | 837,800 | – | 5.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |